Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Go back to Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses
December 8, 2021 7:16 AM EST
BioNTech SE (Nasdaq: BNTX) will hold a digital press conference on Wednesday, December 8, 2021, to... More
December 8, 2021 6:48 AM EST
(Updated - December 8, 2021 6:53 AM EST)
Pfizer (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said a third dose of their vaccine neutralized Omicron in lab tests, according to Dow Jones.
The two-dose regimen was significantly less... More
December 7, 2021 4:11 PM EST
(Raises paragraphs on global alarms)
By Michael Erman and Ludwig Burger
(Reuters) - The Omicron variant can partially evade protection from two doses of Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday.
But the study showed that blood from people who had received two doses of the vaccine and had a prior infection was mostly able to neutralize the variant, suggesting that booster doses of the vaccine could help to fend off infection.
The Omicron variant, first detected in... More
December 7, 2021 3:21 PM EST
Study Shows 40-Fold Reduction in Neutralization Capacity of Pfizer (NYSE: PFE) Vaccines Vs Omicron - DJ
...
More
December 7, 2021 3:14 PM EST
Africa Health's Sigal: Omicron Pfizer Immune Escape Incomplete - Bloomberg
...
More
